Lafora disease and congenital generalized lipodystrophy: a case report
- PMID: 19951852
- PMCID: PMC11917953
- DOI: 10.1016/S1607-551X(09)70572-8
Lafora disease and congenital generalized lipodystrophy: a case report
Abstract
We report a patient with congenital generalized lipodystrophy who had suffered from seizures, myoclonus, ataxia and cognitive decline since late childhood. Lafora disease was diagnosed based on skin biopsy results, which revealed pathognomonic Lafora bodies. The results of genetic analysis for mutations in EPM2A and EPM2B genes were negative. This is the first case report describing an association between congenital generalized lipodystrophy and Lafora disease. Further studies focusing on the relationship between these two diseases and the identification of a third locus for Lafora disease are needed.
Similar articles
-
Three patients with lafora disease: different clinical presentations and a novel mutation.J Child Neurol. 2015 May;30(6):777-81. doi: 10.1177/0883073814535489. Epub 2014 Jul 10. J Child Neurol. 2015. PMID: 25015673
-
Early-onset Lafora body disease.Brain. 2012 Sep;135(Pt 9):2684-98. doi: 10.1093/brain/aws205. Brain. 2012. PMID: 22961547 Free PMC article.
-
Clinical and genetic studies in patients with Lafora disease from Pakistan.J Neurol Sci. 2017 Feb 15;373:263-267. doi: 10.1016/j.jns.2017.01.010. Epub 2017 Jan 4. J Neurol Sci. 2017. PMID: 28131202
-
Lafora progressive myoclonus epilepsy: recent insights into cell degeneration.Recent Pat Endocr Metab Immune Drug Discov. 2012 May;6(2):99-107. doi: 10.2174/187221412800604617. Recent Pat Endocr Metab Immune Drug Discov. 2012. PMID: 22369717 Review.
-
[Lafora disease: a review of the literature].Rev Neurol. 2019 Jan 16;68(2):66-74. Rev Neurol. 2019. PMID: 30638256 Free PMC article. Review.
Cited by
-
Lafora disease: epidemiology, pathophysiology and management.CNS Drugs. 2010 Jul;24(7):549-61. doi: 10.2165/11319250-000000000-00000. CNS Drugs. 2010. PMID: 20527995 Review.
-
Medical management of a child with congenital generalized lipodystrophy accompanied with progressive myoclonic epilepsy: A case report.Medicine (Baltimore). 2019 Nov;98(48):e18121. doi: 10.1097/MD.0000000000018121. Medicine (Baltimore). 2019. PMID: 31770241 Free PMC article.
-
Focus on progressive myoclonic epilepsy in Berardinelli-Seip syndrome.Neurol Sci. 2020 Nov;41(11):3345-3348. doi: 10.1007/s10072-020-04418-1. Epub 2020 May 21. Neurol Sci. 2020. PMID: 32440981
References
-
- Berardinelli W. An undiagnosed endocrinometabolic syndrome: report of 2 cases. J Clin Endocrinol Metab. 1954; 14: 193–204. - PubMed
-
- Seip M. Lipodystrophy and gigantism with associated endocrine manifestations: a new diencephalic syndrome?. Acta Paediatr. 1959; 48: 555–574. - PubMed
-
- Garg A, Wilson R, Barnes R, et al. A gene for congenital generalized lipodystrophy maps to human chromosome 9q34. J Clin Endocrinol Metab. 1999; 84: 3390–3394. - PubMed
-
- Magre J, Delepine M, Khallouf E, et al. Identification of the gene altered in Berardinelli‐Seip congenital lipodystrophy on chromosome 11q13. Nat Genet. 2001; 28: 365–370. - PubMed
-
- Kim CA, Delépine M, Boutet E, et al. Association of a homozygous nonsense caveolin‐1 mutation with Berardinelli‐Seip congenital lipodystrophy. J Clin Endocrinol Metab. 2008; 93: 1129–1134. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources